Zobrazeno 1 - 10
of 193
pro vyhledávání: '"Wah‐Kheong Chan"'
Autor:
Zobair M. Younossi, Saleh A. AlQahtani, Jesús Funuyet-Salas, Manuel Romero-Gómez, Yusuf Yilmaz, Caglayan Keklikkiran, Khalid Alswat, Ming-Lung Yu, Chun-Jen Liu, Jian-Gao Fan, Ming-Hua Zheng, Patrizia Burra, Sven M. Francque, Laurent Castera, Jörn M. Schattenberg, Philip N. Newsome, Alina M. Allen, Mohamed El-Kassas, Sombat Treeprasertsuk, Saeed Hameed, Vincent Wai-Sun Wong, Shira Zelber-Sagi, Hirokazu Takahashi, Takumi Kawaguchi, Marlen I. Castellanos Fernández, Ajay Duseja, Marco Arrese, Mary Rinella, Ashwani K. Singal, Stuart C. Gordon, Michael Fuchs, Wayne Eskridge, Naim Alkhouri, Kenneth Cusi, Rohit Loomba, Jane Ranagan, Achim Kautz, Janus P. Ong, Marcelo Kugelmas, Yuichiro Eguchi, Moises Diago, Lynn Gerber, Brian Lam, Lisa Fornaresio, Fatema Nader, C. Wendy Spearman, Stuart K. Roberts, Wah-Kheong Chan, Marcelo Silva, Andrei Racila, Pegah Golabi, Prooksa Ananchuensook, Linda Henry, Maria Stepanova, Patrizia Carrieri, Jeffrey V. Lazarus
Publikováno v:
JHEP Reports, Vol 6, Iss 7, Pp 101066- (2024)
Background & Aims: Patients with nonalcoholic fatty liver disease (NAFLD)/metabolic dysfunction-associated steatotic liver disease (MASLD) face a multifaceted disease burden which includes impaired health-related quality of life (HRQL) and potential
Externí odkaz:
https://doaj.org/article/89eb6d0343c440378b078cf55412cc72
Autor:
Kim Sui Wan, Wah-Kheong Chan, Muhammad Fadhli Mohd Yusoff, Feisul Mustapha, Halizah Mat Rifin, Kishwen Kanna Yoga Ratnam, Noor Ani Ahmad
Publikováno v:
Annals of Hepatology, Vol 29, Iss 4, Pp 101485- (2024)
Externí odkaz:
https://doaj.org/article/085e65b7c90f4b2d8f17ea39ea157918
Autor:
Wah-Kheong Chan, Kee-Huat Chuah, Ruveena Bhavani Rajaram, Lee-Ling Lim, Jeyakantha Ratnasingam, Shireene Ratna Vethakkan
Publikováno v:
Journal of Obesity & Metabolic Syndrome, Vol 32, Iss 3, Pp 197-213 (2023)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the latest term for steatotic liver disease associated with metabolic syndrome. MASLD is the most common cause of chronic liver disease and is the leading cause of liver-related morb
Externí odkaz:
https://doaj.org/article/552ab1341ac14f4db271158a4ccecbe6
Autor:
Huai Zhang, Rafael S. Rios, Jerome Boursier, Rodolphe Anty, Wah-Kheong Chan, Jacob George, Yusuf Yilmaz, Vincent Wai-Sun Wong, Jiangao Fan, Jean-François Dufour, George Papatheodoridis, Li Chen, Jörn M. Schattenberg, Junping Shi, Liang Xu, Grace Lai-Hung Wong, Naomi F. Lange, Margarita Papatheodoridi, Yuqiang Mi, Yujie Zhou, Christopher D. Byrne, Giovanni Targher, Gong Feng, Minghua Zheng, Yuanyuan Ji
Publikováno v:
Chinese Medical Journal, Vol 136, Iss 3, Pp 341-350 (2023)
Abstract. Background:. Liver biopsy for the diagnosis of non-alcoholic steatohepatitis (NASH) is limited by its inherent invasiveness and possible sampling errors. Some studies have shown that cytokeratin-18 (CK-18) concentrations may be useful in di
Externí odkaz:
https://doaj.org/article/0982b24e160647a4ac40142ad09703fb
Autor:
Kee-Huat Chuah, Wah-Kheong Chan
Publikováno v:
Clinical and Molecular Hepatology, Vol 29, Iss 2, Pp 401-403 (2023)
Externí odkaz:
https://doaj.org/article/d2fa532998bf4001bf2a0b6a643dab09
Autor:
Shi-En Chong, Felicia Chang, Kee-Huat Chuah, Pavai Sthaneshwar, Nik Raihan Nik Mustapha, Sanjiv Mahadeva, Wah-Kheong Chan
Publikováno v:
Annals of Hepatology, Vol 28, Iss 2, Pp 100888- (2023)
Introduction and Objectives: The Hepamet fibrosis score was introduced for the diagnosis of advanced liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). To date, external validation is limited, and its utility in combination wi
Externí odkaz:
https://doaj.org/article/e5c2f62d75484e51a0a74d3602369f5a
Autor:
Wah-Kheong Chan
Publikováno v:
Clinical and Molecular Hepatology, Vol 29, Iss Suppl, Pp S58-S67 (2023)
Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of liver conditions that are characterized by excess accumulation of fat in the liver, and is diagnosed after exclusion of significant alcohol intake and other causes of chronic liver di
Externí odkaz:
https://doaj.org/article/186279c3758a4d9e8e284128920de9d6
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 13 (2022)
Non-alcoholic fatty liver disease (NAFLD) affects an estimated one-quarter of the global adult population and has become one of the leading causes of end-stage liver disease and hepatocellular carcinoma with increased liver-related and overall morbid
Externí odkaz:
https://doaj.org/article/1a0ff86e78c04ca4909bb64d3f8b66a4
Autor:
Yi-Wen Ting, Amanda Shen-Yee Kong, Shamsul Mohd Zain, Wah-Kheong Chan, Hwa-Li Tan, Zahurin Mohamed, Yuh-Fen Pung, Rosmawati Mohamed
Publikováno v:
Clinical and Molecular Hepatology, Vol 27, Iss 3, Pp 486-498 (2021)
Background/Aims 17β-hydroxysteroid dehydrogenase 13 (HSD17B13) variants were recently reported to have significantly lower odds of non-alcoholic fatty liver disease (NAFLD). This is a two-part study that aimed to evaluate the association of HSD17B13
Externí odkaz:
https://doaj.org/article/fdbd1ed6e2544c85bcf51e6b76980210
Publikováno v:
JGH Open, Vol 4, Iss 3, Pp 332-339 (2020)
Liver diseases form a heterogenous group of acute and chronic disorders of varying etiologies. Not only do they result in significant morbidity and mortality, but they also lead to a marked reduction in quality of life, together with a high socioecon
Externí odkaz:
https://doaj.org/article/942e30914b88499baa8062691f81cadc